Xiaorong Pan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
Papers in
-
- Retinoids in leukemia and cellular processes 5
- RNA Interference and Gene Delivery 4
- Oncology 18
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- Zonghai Li (14 shared papers)Bizhi Shi (13 shared papers)Hua Jiang (12 shared papers)Jianhua Tong (17 shared papers)Huiping Gao (7 shared papers)Kesang Li (9 shared papers)Hongyang Wang (5 shared papers)Shengli Yang (5 shared papers)
- Journals
- Oncotarget (4 papers)Frontiers in Oncology (3 papers)Cancer Letters (2 papers)Journal of Controlled Release (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaorong Pan
55 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 337
- Immunology 429
- Oncology 531
- Hepatology 142
- Molecular Biology 732
Countries citing papers authored by Xiaorong Pan
This map shows the geographic impact of Xiaorong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Pan more than expected).
Fields of papers citing papers by Xiaorong Pan
This network shows the impact of papers produced by Xiaorong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Pan. The network helps show where Xiaorong Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaorong Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 259 | |
| 2 | 2006 | 94 | |
| 3 | 2014 | 86 | |
| 4 | 2016 | 82 | |
| 5 | 2017 | 76 | |
| 6 | 2016 | 66 | |
| 7 | 2014 | 62 | |
| 8 | 2009 | 57 | |
| 9 | 2020 | 54 | |
| 10 | 2019 | 49 | |
| 11 | Antimicrobial effect of chitooligosaccharides produced by chitosanase from Pseudomonas CUY8. | 2007 | 46 |
| 12 | 2013 | 39 | |
| 13 | 2016 | 38 | |
| 14 | 2009 | 37 | |
| 15 | 2017 | 37 | |
| 16 | 2019 | 36 | |
| 17 | 2015 | 32 | |
| 18 | 2016 | 30 | |
| 19 | 2014 | 24 | |
| 20 | 2013 | 20 |
About Xiaorong Pan
Xiaorong Pan is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Liver physiology and pathology (5 papers), Retinoids in leukemia and cellular processes (5 papers), Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), MicroRNA in disease regulation (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Cancer Research (337 citations), Immunology (429 citations), Oncology (531 citations), Hepatology (142 citations) and Molecular Biology (732 citations). Xiaorong Pan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zonghai Li, Bizhi Shi, Hua Jiang, Jianhua Tong, Huiping Gao, Kesang Li, Hongyang Wang, Shengli Yang, Jianren Gu and Juan Kong. Their work appears in journals such as Oncotarget, Frontiers in Oncology, Cancer Letters, Journal of Controlled Release and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.